Herbert A. Fritsche, PhD

by | Aug 20, 2023 | Company Details | 0 comments

Dr. Herbert Fritsche is Professor of Laboratory Medicine and Chief of the
Clinical Chemistry Section at The University of Texas, M.D. Anderson Cancer
Center in Houston, Texas. During his 40+ years at M.D. Anderson Cancer Center,
Dr. Herbert Fritsche has focused his research activities on the development and
validation of cancer diagnostics. Dr. Herbert Fritsche has participated in the
validation and FDA clearance process for every commercial serum tumor marker
product currently in use in the United States.

Dr. Herbert Fritsche has served as President of the Clinical Ligand Assay Society
(CLAS) and on various committees for both the CLAS and the American
Association for Clinical Chemistry (AACC). He is a fellow of the National Academy
of Clinical Biochemistry and was awarded the National Award for Contributions in
Education by the AACC; the Outstanding Clinical Chemist Award by the Texas
Section, AACC; a Dean’s Excellence Award for the University of Texas Graduate
School of Biomedical Science; a Distinguished Scientist Award from the CLAS;
and the Johnson and Johnson Award for Outstanding Research and Contributions
to Clinical Biochemistry from the National Academy of Clinical Biochemistry. Dr.
Herbert Fritsche currently serves on the Expert Panel for developing Tumor Marker
Practice Guidelines for the American Society of Clinical Oncology, and the
Laboratory Practice Guidelines Committee for the National Academy of Clinical
Biochemistry. In addition, he serves on the Editorial Board of six international
scientific journals.

Dr. Herbert Fritsche serves as a consultant/advisor to the National Cancer Institute
and for some major international diagnostic companies and biotech start-up
companies. Dr. Herbert Fritsche has published over 170 peer-reviewed scientific
papers, invited articles and book chapters. Dr. Herbert Fritsche holds 3 patents
and has 2 other applications on file. He has lectured extensively for many years at
international and national meetings.